Min Xu

Statistics

Publications

Citations

H-Index

Active since

2016

Affiliations

Nanjing University of Chinese Medicine(Current)

Min Xu is an author at Nanjing University of Chinese Medicine specializing in migraine pharmacotherapy, nrf2 pathway activation, and migraine pharmacology.

ORCID

Publications per year

2016–2023

Publications

Rutaecarpine alleviates migraine in nitroglycerin-induced mice by regulating PTEN/PGK1 signaling pathway to activate NRF2 antioxidant system

Min Xu, Zhenhua Shi, Ziyang He et al. · Biomedicine & Pharmacotherapy · 2023 · 17 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Single chain antibody fragments with pH dependent binding to FcRn enabled prolonged circulation of therapeutic peptide in vivo

Yangsheng Qiu, Wei Lv, Min Xu et al. · Journal of Controlled Release · 2016 · 12 citations

Pharmacy, Immunology, Molecular Pharmaceutics +15

1–2 of 2